Ordenar

Buscar

01/01/2026 Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans
Galbiati, F, Plessow, F, Plummer, L, Campbell, MB, Nazarloo, S, Carter, CS, Davis, JM, Miller, KK, Carroll, RS, Kaiser, UB, Seminara, SB, Aulinas, A, Lawson, EA. Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans. JOURNAL OF NEUROENDOCRINOLOGY. 2026; 38(1)DOI:10.1111/jne.70114. PMID:41273106. IF:4.100(Q1/3D).
01/01/2026 Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males
Teller, M, Giordano, A, González-Munoza, C, Gordillo, J, Bertoletti, F, Sánchez-Reus, F, Garcia-Planella, E. Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males. Gastroenterologia y Hepatologia. 2026; 49(1)DOI:10.1016/j.gastrohep.2025.502558. PMID:40930415. IF:1.900(Q3/7D).
01/01/2026 Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU
Ramos, CR, Sard, MC, Carballo-Folgoso, L, Ruiz-Rodríguez, J, Moya, MIC, Teller, M, Clotet, AF, Cortés, IL, San Martín, LZ, Moreno, CO, Rivas, C, Cuellar, MA, Elorza, A, Gisbert, J, Martinez, MR, Poceiro, JC, Brunet, E, Caravaca, C, Rey, IB, Piñero, GS, Diaz, AP, Orenga, C, Carrilloramos, MJ, Montero, MG, Sandoval, CT, Velázquez, LM, Olmedo-Martín, R, Catalá, AC, Alonso,, Molina, IGDL, Molina, F, Salmón, P, Giordano, A, Moranta, FR, Zabana, Y, Planella, EG. Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1197. PMID:. IF:8.700(Q1/1D).
01/01/2026 Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU
Casanova, MJ, Garcia, RMD, Ramos, CL, Camba, AH, Gargayo-Puyuelo, C, Senosiain, BC, Gismero, FM, Pagola, L, Cruañas, AA, Giordano, A, Diaz, AP, Velázquez, LM, Robledo-Andrés, P, Regueiro, C, Gonzalez, MS, Jara, RA, Santos, DC, Glaría, EB, Marquès-Camí, M, Trastoy, PV, Acosta, MBD, de la Osa, DR, Luque, RS, Teller, M, De Célix, CR, Almela, P, Font-Ordeig, G, Bujanda, L, Orenga-Sánchez, C, Oliveras-Font, B, Alvarez, PGI, Sánchez, RM, Guillena, PGD, Arce, NM, Martinez, IP, Alonso, FJG, Ramos, CR, Moral, ED, Chaparro, M, Gisbert, J. Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.960. PMID:. IF:8.700(Q1/1D).
01/01/2026 Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA
De Célix, CR, Granja, A, Iborra, M, Alonso, FJG, Vela, M, de Castro, L, García-Sola, C, Barrero, S, Trastoy, PV, Andrés, PR, Riestra, S, Diaz, AP, Santos, DC, Camps, B, Gisbert, J, García, MJ, Palomares, MTDL, Lozano, OM, de la Cruz, DR, López, E, Pascual, CM, Izquierdo, S, Flores, EI, Iglesias, RF, Argüelles-Arias, F, Martin, D, Ramírez, MAR, Villaamil, PV, Martinez, AMT, Ramos, CR, Velázquez, LM, Ciria, MM, Brunet, E, Zabana, Y, Villarroya, RP, Altadill, A, Moral, ED, Mateu, PN, Acosta, MBD, San Jose, FB. Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.069. PMID:. IF:8.700(Q1/1D).
01/01/2026 Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia
Calvo, M, Fernández-Felix, BM, Jiménez, IO, Guardia, JL, Menéndez, SR, Gismero, FM, Parga, MLD, Trastoy, PV, Vela, M, Carrasco, NM, Gargallo-Puyuelo, C, Ramos, CR, Arranz, MDM, Rivas, C, Capón, JG, Garcia, LA, Casbas, AG, San Jose, FB, Gonzalez, S, Lucia, M, Elorza, A, Sepulcre, MFG, Fernández-Salazar, L, Mínguez, A, Quiñones, M, Taxonera, C, Barreiro-de Acosta, M, Diaz, AP, Flores, EI, Cano, MP, Sese, E, Casals, DB, Bas-Cutrina, F, Glaría, EB, Moreno, AZG, Poceiro, JC, Lopez, LR, Moral, ED, Chaparro, M, Gisbert, J. Safety of biologic and small molecule therapies in IBD patients with previous cancer: risk of recurrence or new neoplasia. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.897. PMID:. IF:8.700(Q1/1D).
01/01/2026 Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA
de Célix, CR, Ricart, E, Martín-Arranz, MD, de Francisco, R, García-Alonso, FJ, Mesonero, F, Gomollón, F, de Castro, L, Ramos, L, García-López, S, Arias, L, Mañosa, M, Iglesias, E, Calvet, X, Bolufer, CS, Casanova, MJ, Pérez-Calle, JL, Giordano, A, Sierra-Ausín, M, Vera, I, Navarro-Llavat, M, Lorente, R, Piqueras, M, Rivero, M, Guardiola, J, Esteve, M, Coronel, AF, Rodríguez-Lago, I, Ponferrada-Díaz, A, Ber, Y, Tardillo, C, Márquez, L, Carpio, D, Taxonera, C, Bermejo, F, Busquets, D, Camps, B, Gutiérrez, A, García-Sepulcre, MF, Barreiro-de Acosta, M, Marín-Jiménez, I, Huguet, JM, Fernández-Salazar, LI, Jaó, J, Rodríguez-Gutiérrez, C, Martinez-Flores, C, Bujanda, L, Lucendo, AJ, Sesé, E, Andrés, PR, Ginard, D, Vega, P, Riera, J, Pajares, R, Van Domselaar, M, Almela, P, Pérez, TM, Muñoz-Villafranca, C, Varela, P, Argüelles-Arias, F, Nos, P, Alcaín, G, Hernández, L, Fernández, H, Muñoz, F, Gilabert, P, Navas-López, VM, de la Piscina, PR, Sánchez, LB, Gil, JL, Valldosera, G, Muñoz, RA, Frago, S, Domènech, E, Chaparro, M, Gisbert, JP. Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA. ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2026; 63(1)DOI:10.1111/apt.70312. PMID:40778752. IF:6.700(Q1/1D).
01/01/2026 Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group
Marquès-Camí, M, Vergés, L, Gonzalez, AE, Huguet, JM, Mateos, AMC, Caravaca, C, Molina, IGD, Suárez, C, Carballo-Folgoso, L, Vivo, MG, Cuadro, CP, Vicente, GT, Martin, MDCL, Ramos, CR, Jimenez, BV, Clotet, AF, Sandoval, CT, Torres, VM, Intriago, AC, Brunet, E, Martín, J, Marin, CAT, Medina, LT, Lozano, OM, Mínguez, A, Velázquez, LM, Sard, MC, Zabana, Y. Small bowel capsule endoscopy and ileocolonoscopy for activity grading in ileal Crohn's disease, a comparative analysis. Results from the CAPITER study, a multicenter study from the Young GETECCU Group. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.468. PMID:. IF:8.700(Q1/1D).
01/01/2026 Clinical and biological factors as predictors of mucosal healing in moderate ulcerative colitis treated with steroids
Ciria, MM, Guardia, JL, Piñero, GS, Sard, MC, Arranz, EM, Zabana, Y, Llavat, MN, Teller, M, Planella, EG, Casals, DB, Miquel, DM, Juan-Ramón, P, Casbas, AG, Ferrer, AV, Viso, LAM, Paz, GB, Alonso, FJG, Tirado, MR, Chaparro, M, Menéndez, SR, Ochoa, OM, Rodríguez-Lago,, Acosta, MBD, Rodríguez-Fortúnez, P, Moral, ED. Clinical and biological factors as predictors of mucosal healing in moderate ulcerative colitis treated with steroids. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.463. PMID:. IF:8.700(Q1/1D).
01/01/2026 Feasibility and safety of endoscopic submucosal dissection In inflammatory bowel disease (ESDEUR-IBD): an European retrospective study
García, MJ, Fraile, M, Katinios, G, Gubbiotti, A, Argyriou, K, Neri, B, Gonzalez, AE, Partida, IG, Gavric, A, Loly, JP, Parga, MLD, Fousekis, F, Quintana, LC, Suchanek, S, Caron, B, Guardia, JL, Terán, A, Abalos, JG, Poortmans, PJ, Hernández, LA, García, AL, Santos, DC, Pallares, PD, Elorza, A, Lopez, LR, Bednarska, O, Savarino, E, Manolakis, A, Mancone, R, Albéniz, E, de Frutos, D, Vieujen, S, Jesús, ARD, Skamnelos, A, Schaefer, M, Ribas, AM, Truyens, M, Romero, DG, López, RH, Tirado, MR. Feasibility and safety of endoscopic submucosal dissection In inflammatory bowel disease (ESDEUR-IBD): an European retrospective study. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1281. PMID:. IF:8.700(Q1/1D).
01/01/2026 Prevalence and Determinants of Anal and Oral Human Papillomavirus Infection in Men with Inflammatory Bowel Disease: Interim Results from the PAPIMALE Study
Giordano, A, Szafranska, J, Abalos, JG, Muñoza, CG, Vila, CG, Bertoletti, F, Gomez, ER, Planella, EG. Prevalence and Determinants of Anal and Oral Human Papillomavirus Infection in Men with Inflammatory Bowel Disease: Interim Results from the PAPIMALE Study. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1512. PMID:. IF:8.700(Q1/1D).
01/01/2026 SHORT-TERM HUMAN ALBUMIN THERAPY IMPROVES SERUM SODIUM CONCENTRATION AND REDUCES MORTALITY IN PATIENTS WITH CIRRHOSIS AND DILUTIONAL HYPONATREMIA
Juanola, A, Moreta, M, Sole, C, Pérez-Guasch, M, Ginès, JG, Soria, A, Cuyas, B, Martin-Llahi, M, Ma, A, Pompili, E, Amorós, M, Cruceta, A, Diestro, S, Domenech, G, Rios, J, Sánchez, J, Fabrellas, N, Graupera, I, Pose, E, Gines, P. SHORT-TERM HUMAN ALBUMIN THERAPY IMPROVES SERUM SODIUM CONCENTRATION AND REDUCES MORTALITY IN PATIENTS WITH CIRRHOSIS AND DILUTIONAL HYPONATREMIA. HEPATOLOGY. 2026; 83(1)DOI:. PMID:. IF:15.800(Q1/1D).
01/01/2026 Clinical outcomes in the implementation of peroral endoscopic myotomy (POEM): Results from the Spanish multicenter registry
Estremera-Arevalo, F, Bravo-Meléndez, S, Hijos-Mallada, G, Guarner-Argente, C, Murzi, M, Rodriguez-Santiago, E, de Tejada, AH, Uchima-Koecklin, H, Miranda-Garcia, P, Barquero-Declara, D, Riesco-López, JM, De Maria-Pallarés, P, Fernández-Esparrach, MG, Sánchez-Yagüe, A, Aresté-Anduaga, I, Gonzalez-Gete, G, Sanchez-Vegazof, CT, Penas-Garcia, B, Parejo-Carbonell, S, Martinez-Sánchez, A, Rojo, E, Mata-Bilbao, A, Araujo, IK, Montori, S, Gómez, M, Albeniz, E. Clinical outcomes in the implementation of peroral endoscopic myotomy (POEM): Results from the Spanish multicenter registry. Gastroenterologia y Hepatologia. 2026; 49(1)DOI:10.1016/j.gastrohep.2025.502527. PMID:40769466. IF:1.900(Q3/7D).
01/01/2026 Impact on peripheral catheter failure with the use of an extension set with integrated needleless connector compared with a straight hub: a prospective quasi-experimental study
Piriz-Marabajan, M, Rombauts, A, Roch-Villaverde, N, Cortes-Palacios, AP, Fernandez-Piqueras, E, Serrano-Condal, S, Taltavull-Menendez, M, Grillo, S, Simonetti, AF, Duch, P, Pomar-Solchaga, V, Escolà-Vergé, L, Lopez-Contreras, J. Impact on peripheral catheter failure with the use of an extension set with integrated needleless connector compared with a straight hub: a prospective quasi-experimental study. JOURNAL OF HOSPITAL INFECTION. 2026; 167DOI:10.1016/j.jhin.2025.09.009. PMID:41075840. IF:3.100(Q1/3D).
01/01/2026 Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry
Fernández-Lozano, D, Domínguez-Alvaro, M, Narváez, J, Garrido-Puñal, N, De Miguel, E, Estrada-Alarcon, P, Hernández-Rodríguez, I, Silva-Diaz, M, Belzunegui, JM, Moriano, C, Martín, JS, Calvo, I, Aldasoro, V, Abasolo, L, Loricera, J, Moya-Alvarado, P, García-Villanueva, MJ, Sánchez-Alonso, F, Castañeda, S, Hernández, JL, Blanco, R. Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry. RHEUMATOLOGY. 2026; 65(1)DOI:10.1093/rheumatology/keaf689. PMID:41452742. IF:4.400(Q1/1D).
01/01/2026 Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I
Ramos, D, Francesqui, J, Bollo, E, Villar, A, Florez, P, Balcells, E, Castaño, G, Pinillos-Robles, EJ, Godoy-Mayoral, R, Lopez-Muñiz, B, Soler-Sampere, MJ, Castillo, D, Rafecas-Codern, A, Mariscal-Aguilar, P, Portillo, K, Gomez-Carrera, L, Bonilla, G, Millan-Billi, P, Hernández-González, F, Sellarés, J. Mortality predictors in pulmonary sarcoidosis: results from the Spanish cohort SARCO-I. RESPIRATORY MEDICINE. 2026; 251DOI:10.1016/j.rmed.2025.108591. PMID:41418888. IF:3.100(Q2/4D).
01/01/2026 A New Horizon for an Old Disease: Modern Strategies for Approaching Chronic Cough
Domingo, C, Crespo-Lessmann, A, McGarvey, L. A New Horizon for an Old Disease: Modern Strategies for Approaching Chronic Cough. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(1)DOI:10.1016/j.arbres.2025.07.020. PMID:40887323. IF:9.200(Q1/1D).
01/01/2026 Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD
Casanova, C, Gonzalez-Dávila, E, De Torres, JP, Cabrera, C, Cosio, BG, O'Donnel, DE, Martínez-Gonzalez, C, Solanes, I, Fuster, A, Gotera, C, Marin, A, Amado, C, Iscar, M, Marin, JM, Neder, JA, Feu, N, Soriano, JB, López-Campos, JL, Divo, M, Peces-Barba, G, Celli, BR. Lung Diffusing Capacity Improves the Prognostic Validity of the GOLD Spirometric Staging in COPD. ARCHIVOS DE BRONCONEUMOLOGIA. 2026; 62(1)DOI:10.1016/j.arbres.2025.05.004. PMID:40447521. IF:9.200(Q1/1D).
01/01/2026 Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease
Viglino, J, Perea, L, Garcia-Nuñez, M, Rodrigo-Troyano, A, Torrego, A, Domínguez-Alvarez, M, Villar, J, Carrizosa, X, Quero, S, Gabaldon, T, Willis, JR, Saus, E, Gea, J, Santos, S, Camps, P, Agusti, A, Monso, E, Sibila, O, Faner, R. Characterisation of the gut-lung axis microbiome in clinically stable patients with chronic obstructive pulmonary disease. EBioMedicine. 2026; 123DOI:10.1016/j.ebiom.2025.106099. PMID:41483682. IF:10.800(Q1/1D).
01/01/2026 The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization
Domingo, P, Stapleton, JT. The hidden threat: HBV reactivation in the era of antiretroviral therapy optimization. AIDS. 2026; 40(1)DOI:10.1097/QAD.0000000000004369. PMID:41489321. IF:3.100(Q2/4D).
01/01/2026 Standardization of Sinonasal Anatomical Terminology in Spanish: An Expert Consensus
Villatoro-Sologaistoa, JC, Villatoro-Sologaisto, JC, Casasayas-Plass, M, Martel-Martin, M, Alfonso-Carrillo, C, Armengot-Carceller, M, Dominguez-Sosa, MS, Fernandez-Liesa, R, Garcia-Lliberós, A, Gil-Melcón, M, González-Compta, X, López-Alvarez, F, López-Chacón, M, Lobo-Duro, D, Mata-Castro, N, Monjas-Cánovas, I, Moreno-Luna, R, Pardo-Muñoz, L, Pinilla-Urraca, M, Santamaría-Gadea, A, Santos-Pérez, J, Valcárcel-Martin, F, Villacampa-Aubá, JM, del Cuvillo-Bernal, A, Sánchez-Gómez, S, Massegur-Solench, H, Bernal-Sprekelsen, M, Alobid, I. Standardization of Sinonasal Anatomical Terminology in Spanish: An Expert Consensus. Acta Otorrinolaringologica Espanola. 2026; 77(1)DOI:10.1016/j.otorri.2025.512275. PMID:. IF:(Q/D).
01/01/2026 Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe
Ammar, D, Sanges, C, Henderson, D, Schapitz, I, Hudecek, M, Luu, M, Schüssler-Lenz, M, Buchholz, C, Franz, P, Reiche, K, Köhl, U, Ifrah, N, Quesnel, B, Thermeli, M, Kersten, MJ, Locatelli, F, D'Amore, ML, Bonini, C, Casucci, M, Philippar, U, Doeswijk, R, Thielen, F, Uyl-de Groot, C, Theelen, J, Schröder, B, Kremer, A, Quaranta, M, Prosper, F, Van den Brulle, J, Grawunder, U, Donnadieu, E, Galy, A, Ferrand, C, Worel, N, Busch, D, Briones, J, Sellner, L, Kuball, J, Sureda, A, Awigena-Cook, J. Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe. CYTOTHERAPY. 2026; 28(1)DOI:10.1016/j.jcyt.2025.09.007. PMID:41217312. IF:3.200(Q2/3D).
01/01/2026 HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort study
Salas, MQ, Moya, TA, Pasic, I, González, MB, Gómez, MA, Fox, L, Artigas, MDP, Santamaria, A, González, MDQ, Salinas, AS, Camacho, JMS, Alvaro, VI, Abdallahi-Lefdil, Z, Navascues, JC, Pardo, L, Fernández-Luis, S, Suárez, LPV, Villar, S, Beorlegui-Murillo, P, Esquirol, A, Garcia, II, Mussetti, A, Lavilla, E, Lopez-Marin, J, Filaferro, S, Balsalobre, P, Bento, L, Law, A, Viswabandya, A, Michelis, F, Mattsson, J, Alibhai, S, Rovira, M, Kim, DDW, Sured, A, Kumar, R. HCT Frailty Scale (HCT-FS) for assessing frailty in adult candidates for allogeneic haematopoietic cell transplantation: an international prospective, observational cohort study. Eclinicalmedicine. 2026; 91DOI:10.1016/j.eclinm.2025.103753. PMID:41567713. IF:10.000(Q1/1D).
01/01/2026 Influence of spot sign on the association between rapidly achieving blood pressure reduction and intracerebral haemorrhage outcomes
Sousa, JA, Pancorbo, O, Simonetti, R, Llull, L, Coscojuela, P, Blasco, J, Perez-Hoyos, S, García-Tornel, A, Rodriguez-Villatoro, N, Rizzo, F, Muchada, M, Bartolomé, I, Olivé-Gadea, M, Pagola, J, Rubiera, M, Amaro, S, Silva, Y, Prats-Sanchez, L, Molina, CA, Sargento-Freitas, J, Rodriguez-Luna, D. Influence of spot sign on the association between rapidly achieving blood pressure reduction and intracerebral haemorrhage outcomes. European Stroke Journal. 2026; 11(1)DOI:10.1093/esj/aakaf024. PMID:41614513. IF:4.500(Q1/2D).
01/01/2026 Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial
Allen, JA, Querol, L, Suresh, N, Remmerie, A, Mole, T, McCoy, K, Butler, L, van Hoorick, B, Kuwabara, S, van Doorn, PA, Lewis, RA. Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial. Therapeutic Advances in Neurological Disorders. 2026; 19DOI:10.1177/17562864251405202. PMID:41583073. IF:4.100(Q1/2D).
01/01/2026 A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial
Julià, A, Jaén, I, Giménez, MC, García-Palacios, A, Pascual, JC, Estévez, AS, Lara, A, Méndez, I, Romero, S, Puntí, J, Soler, J, Solé-Casals, J, López-Solà, M, Vega, D. A Smartphone-Based Psychological Intervention for Nonsuicidal Self-Injury (Kalmer App): Protocol for a Multicenter Double-Blind Randomized Controlled Trial. Jmir Research Protocols. 2026; 15DOI:10.2196/86413. PMID:41592792. IF:(Q/D).
01/01/2026 Exploring the nexus of cognition and insight in euthymic bipolar patients
Massons, C, Cobo, J, Navarra-Ventura, G, Vicent-Gil, M, Serra-Blasco, M, Jubert, A, Agut, M, Palao, DJ, Cardoner, N. Exploring the nexus of cognition and insight in euthymic bipolar patients. EUROPEAN JOURNAL OF PSYCHIATRY. 2026; 40(1)DOI:10.1016/j.ejpsy.2025.100336. PMID:. IF:1.500(Q3/7D).
01/01/2026 Sex differences in neurocognitive response to metacognitive training in first-episode psychosis: Implications for personalized interventions
Verdaguer-Rodríguez, M., Comas, J.O., López-Carrilero, R., Díaz-Cutraro, L., Espinosa, V., Ruiz-Delgado, I., Barrigón, M.L., Grasa, E., Pousa, E., González-Higueras, F., Cid, J., Lorente-Rovira, E., Barajas, A., Ochoa, S.. Sex differences in neurocognitive response to metacognitive training in first-episode psychosis: Implications for personalized interventions. Archives of Womens Mental Health. 2026; 29(1)DOI:10.1007/s00737-025-01637-3. PMID:41661387. IF:2.700(Q2/4D).
01/01/2026 Cerebrospinal Fluid Fatty Acids, Hypothalamic Inflammation, and Weight Loss in Human Obesity: A Longitudinal Study
Pané, A, Videla, L, Calvet-Mirabent, A, Castro-Barquero, S, Viaplana, J, Vaqué-Alcázar, L, Ibarzabal, A, Rozalem-Aranha, M, Bejanin, A, Moize, V, Vidal, J, De Hollanda, A, Ortega, E, Barroeta, I, Camacho, V, Chiva-Blanch, G, Fortea, J, Jiménez, A. Cerebrospinal Fluid Fatty Acids, Hypothalamic Inflammation, and Weight Loss in Human Obesity: A Longitudinal Study. DIABETES. 2026; 75(1)DOI:10.2337/db25-0595. PMID:41247745. IF:7.500(Q1/1D).
01/01/2026 Exploiting Generative Models for Downstream Classification Tasks on Latent Spaces Using 3D Brain MRI Scans: A Down Syndrome Case Study
Malé, J, Fortea, J, Rozalem-Aranha, M, Martínez-Abadías, N, Sevillano, X. Exploiting Generative Models for Downstream Classification Tasks on Latent Spaces Using 3D Brain MRI Scans: A Down Syndrome Case Study. Pattern Recognition And Image Analysis, Ibpria 2025, Pt Ii. 2026; 15938DOI:10.1007/978-3-031-99568-2_11. PMID:. IF:(Q/D).
01/01/2026 Intraoperative flow cytometry for brain tumor margin evaluation
Aibar-Durán, JA. Intraoperative flow cytometry for brain tumor margin evaluation. JOURNAL OF NEUROSURGERY. 2026; 144(1)DOI:10.3171/2025.7.JNS251696. PMID:. IF:3.600(Q1/2D).
01/01/2026 Consensus document on the diagnosis and treatment of acute kidney injury
Terrades, NR, Benitez, PR, Gallardo, JMU, De Valdenebro, M, Salgueira, M, Andujar, AM, Martins, J, Ramos-Gali, A, Moreno, JA, de la Cuerda, C, Lloret, MJ, Menéndez, D, Acosta-Ochoa, I, Romero-González, G, Poch, E. Consensus document on the diagnosis and treatment of acute kidney injury. NEFROLOGIA. 2026; 46(1)DOI:10.1016/j.nefro.2025.501360. PMID:. IF:2.600(Q2/4D).
01/01/2026 Shaping the future one slice at a time: How 3D organotypic tumour slice models are driving drug discovery in ovarian cancer
Edwards, M, Caruana, P, Escar, M, Céspedes, MV. Shaping the future one slice at a time: How 3D organotypic tumour slice models are driving drug discovery in ovarian cancer. Translational Oncology. 2026; 63DOI:10.1016/j.tranon.2025.102633. PMID:41351993. IF:4.100(Q2/3D).
01/01/2026 Preoperative test requests for elective surgeries of different complexity: Appropriateness and interhospital variability
Sánchez-Hidalgo, A, Barallobre, IU, Ribas, IB, Parga, EB, Bernaras, MA, Sachez, GG, Cirera, DS, Moraga, FJG, Gorostiza, I, Parra, RD, Gómez, SA, Keenoy, PM, Figuls, MR, Requeijo, C. Preoperative test requests for elective surgeries of different complexity: Appropriateness and interhospital variability. JOURNAL OF CLINICAL ANESTHESIA. 2026; 108DOI:10.1016/j.jclinane.2025.112033. PMID:41106116. IF:5.100(Q1/1D).
01/01/2026 ASSOBRAFIR clinical practice guidelines in respiratory physical therapy: Exercise-based interventions in people with chronic obstructive pulmonary disease (COPD)
Camillo, CA, Di Lorenzo, VAP, Malaguti, C, de Carvalho, CRF, Ramos, EMC, Pitta, FD, Velloso, M, Hernandes, NA, Mesquita, R, Mendes, RG, Pinto, ACPN, Fernandes, ATDS, Gulart, AA, Silveira, BMF, Oliveira, CC, Ohara, DG, Vieira, DRS, Pereira, HLA, Arcuri, JF, Monteiro, KS, Isoppo, KD, Fontanela, LC, Neves, LMT, Cahalin, LP, Janahú, LTA, Mendes, LPD, Formiga, MF, Karloh, M, Reboredo, MM, Rehder-Santos, P, Abreu, RM, Rocha, RSB, Carneiro, SR, Santino, TA, Melo, VSQ, Mesquita, FOS, Cacau, LAP, Cipriano, G Jr, Lanza, F. ASSOBRAFIR clinical practice guidelines in respiratory physical therapy: Exercise-based interventions in people with chronic obstructive pulmonary disease (COPD). Brazilian Journal of Physical Therapy. 2026; 30(1)DOI:10.1016/j.bjpt.2025.101539. PMID:41106351. IF:3.200(Q1/1D).
01/01/2026 Developing evidence-based cancer prevention recommendations: Methodology of the World Code Against Cancer Framework to create region-specific codes
Espina, C, Ritchie, D, Feliu, A, Canelo-Aybar, C, D'Souza, E, Mitrou, PN, Carvalho, AL, Schüz, J, Zeeb, H. Developing evidence-based cancer prevention recommendations: Methodology of the World Code Against Cancer Framework to create region-specific codes. INTERNATIONAL JOURNAL OF CANCER. 2026; 158(1)DOI:10.1002/ijc.70068. PMID:40741905. IF:4.700(Q1/3D).
01/01/2026 European Code Against Cancer, 5th edition - organised cancer screening programmes
Toes-Zoutendijk, E, Arbyn, M, Auvinen, A, Baldwin, D, Castells, X, Decensi, A, Hofvind, S, Ivanus, U, Senore, C, Thorat, M, van der Aalst, C, Pinto, ACPN, Bracchiglione, J, Feliu, A, Zeeb, H, D'Souza, E, Ritchie, D, Espina, C, Carvalho, AL, Lansdorp-Vogelaar, I. European Code Against Cancer, 5th edition - organised cancer screening programmes. Molecular Oncology. 2026; 20(1)DOI:10.1002/1878-0261.70197. PMID:41542798. IF:4.500(Q2/3D).
01/01/2026 European Code Against Cancer, 5th edition - tobacco and nicotine containing products, second-hand smoke, alcohol and cancer
Feliu, A, Anderson, AS, Bauld, L, Fernández, E, Leitzmann, M, Morris, S, Srour, B, Vardavas, C, Vlad, I, Vuik, S, Weijenberg, M, Alvarado-Villacorta, R, Canelo-Aybar, C, Zeeb, H, Schüz, J, D'Souza, E, Ritchie, D, Espina, C, Bakogianni, I, Riboli, E. European Code Against Cancer, 5th edition - tobacco and nicotine containing products, second-hand smoke, alcohol and cancer. Molecular Oncology. 2026; 20(1)DOI:10.1002/1878-0261.70177. PMID:41542791. IF:4.500(Q2/3D).
01/01/2026 European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancer
Thorat, MA, Arbyn, M, Baldwin, D, Castells, X, Hofvind, S, Ivanus, U, Senore, C, Toes-Zoutendijk, E, van der Aalst, C, Canelo-Aybar, C, Fernández-Sáenz, FK, Feliu, A, Zeeb, H, Carvalho, AL, D'Souza, E, Ritchie, D, Espina, C, Lansdorp-Vogelaar, I, Decensi, A. European Code Against Cancer, 5th edition - hormone replacement therapy, other common medical therapies and cancer. Molecular Oncology. 2026; 20(1)DOI:10.1002/1878-0261.70158. PMID:41250966. IF:4.500(Q2/3D).
01/01/2026 Educational inequalities in smoking-attributable mortality in Europe: Understanding trends between 2000 and 2020
Boderie, NW, Van Raalte, A, Been, JV, Bopp, M, Bronnum-Hansen, H, Deboosere, P, Eikemo, TA, Kalediene, R, Leinsalu, M, Long, D, Martikainen, P, Östergren, OM, Rodríguez-Sanz, M, van Lenthe, FJ, Nusselder, WJ. Educational inequalities in smoking-attributable mortality in Europe: Understanding trends between 2000 and 2020. PUBLIC HEALTH. 2026; 250DOI:10.1016/j.puhe.2025.106058. PMID:41274099. IF:3.200(Q1/3D).